Faeth Therapeutics Inc (FTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Operating Expenses | 7,274 | 8,274 | 7,823 | 7,787 | 8,730 |
| Operating Income | -7,274 | -8,274 | -7,823 | -7,787 | -8,730 |
| Interest Expense | 0 | 17 | 21 | 24 | 28 |
| Other Income | 410 | 521 | 591 | 669 | 766 |
| Pre-tax Income | -6,864 | -7,770 | -7,253 | -7,142 | -7,992 |
| Net Income Continuous | -6,864 | -7,770 | -7,253 | -7,142 | -7,992 |
| Net Income | $-6,864 | $-7,770 | $-7,253 | $-7,142 | $-7,992 |
| EPS Basic Total Ops | -5.45 | -6.15 | -5.77 | -5.69 | -6.40 |
| EPS Basic Continuous Ops | -5.45 | -6.17 | -5.77 | -5.69 | -6.38 |
| EPS Diluted Total Ops | -5.45 | -6.15 | -5.77 | -5.69 | -6.40 |
| EPS Diluted Continuous Ops | -5.45 | -6.17 | -5.77 | -5.69 | -6.38 |
| EPS Diluted Before Non-Recurring Items | -5.40 | -5.40 | -5.80 | N/A | N/A |
| EBITDA(a) | $-7,240 | $-7,943 | $-7,491 | $-7,459 | $-8,399 |